Page last updated: 2024-08-24

gemcitabine and Scleroderma, Localized

gemcitabine has been researched along with Scleroderma, Localized in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
De Haes, P; Morren, MA; Noƫ, E; Van Cutsem, E; Van den Oord, JJ; Verhulst, L; Verslype, C1
Huang, WW; McGregor, S; Nyckowski, T1

Reviews

1 review(s) available for gemcitabine and Scleroderma, Localized

ArticleYear
Scleroderma-like cutaneous lesions during treatment with paclitaxel and gemcitabine in a patient with pancreatic adenocarcinoma. Review of literature.
    International journal of dermatology, 2018, Volume: 57, Issue:9

    Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Eruptions; Gemcitabine; Humans; Male; Middle Aged; Paclitaxel; Pancreatic Neoplasms; Scleroderma, Localized

2018

Other Studies

1 other study(ies) available for gemcitabine and Scleroderma, Localized

ArticleYear
A case of gemcitabine-related acute lipodermatosclerosis.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2019, Volume: 25, Issue:5

    Topics: Acute Disease; Antimetabolites, Antineoplastic; Deoxycytidine; Dermatitis; Female; Gemcitabine; Humans; Middle Aged; Pancreatic Neoplasms; Scleroderma, Localized

2019